Literature DB >> 21508343

Recent advances on the role of cytokines in atherosclerosis.

Hafid Ait-Oufella1, Soraya Taleb, Ziad Mallat, Alain Tedgui.   

Abstract

Atherosclerosis is a chronic inflammatory disease of the arterial wall driven by innate and adaptive immune responses. Inflammation controls the development and the destabilization of arterial plaque. Cells involved in the atherosclerotic process secrete and are activated by soluble factors, known as cytokines. Important recent advances in the comprehension of the mechanisms of atherosclerosis have provided evidence for a dual role of cytokines: proinflammatory and T helper-1-related cytokines promote the development and progression of the disease, whereas antiinflammatory and regulatory T cell-related cytokines exert clear antiatherogenic activities. This review focuses on recent advances regarding the role of cytokines, with the exception of chemokines, in the development, progression, and complications of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508343     DOI: 10.1161/ATVBAHA.110.207415

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  196 in total

1.  Association between three single nucleotide polymorphisms in eotaxin (CCL 11) gene, hexanucleotide repetition upstream, severity and course of coronary atherosclerosis.

Authors:  J Máchal; A Vašků; V Kincl; M Hlavna; V Bartáková; M Jurajda; J Meluzín
Journal:  J Appl Genet       Date:  2012-07-07       Impact factor: 3.240

2.  Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Authors:  Kamal H Sharma; Komal H Shah; Iva Patel; Alap K Patel; Subhash Chaudhari
Journal:  Indian Heart J       Date:  2015-08-06

3.  Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.

Authors:  Roshni Srivastava; Jiasheng Zhang; Gwang-Woong Go; Anand Narayanan; Timothy P Nottoli; Arya Mani
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

4.  Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study.

Authors:  Orla Ni Mhuircheartaigh; Cynthia S Crowson; Sherine E Gabriel; Veronique L Roger; L Joseph Melton; Shreyasee Amin
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

Review 5.  Inflammation and cerebral aneurysms.

Authors:  Koji Hosaka; Brian L Hoh
Journal:  Transl Stroke Res       Date:  2013-12-11       Impact factor: 6.829

Review 6.  Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Daniel M S Raper; Dale Ding; Nohra Chalouhi; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-09-20       Impact factor: 6.829

7.  Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells.

Authors:  Huai-Na Qiu; Bin Liu; Weihua Liu; Shiming Liu
Journal:  Mol Cell Biochem       Date:  2015-09-19       Impact factor: 3.396

Review 8.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

9.  Association of systemic inflammation with epicardial fat and coronary artery calcification.

Authors:  Sören Gauss; Lutz Klinghammer; Alina Steinhoff; Dorette Raaz-Schrauder; Mohamed Marwan; Stephan Achenbach; Christoph D Garlichs
Journal:  Inflamm Res       Date:  2015-03-13       Impact factor: 4.575

10.  Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Authors:  Dorette Raaz-Schrauder; Michael G Schrauder; Christian Stumpf; Piotr Lewczuk; Tobias Kilian; Barbara Dietel; Christoph D Garlichs; Christian Schlundt; Stephan Achenbach; Lutz Klinghammer
Journal:  Heart Vessels       Date:  2017-05-31       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.